• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉应用后生物类似依泊汀kappa 和其他重组促红细胞生成素的兴奋剂检测控制。

Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.

机构信息

Anti-Doping Laboratory, Mitsubishi Chemical Medience Corporation, Tokyo, Japan.

出版信息

Drug Test Anal. 2011 Nov-Dec;3(11-12):798-805. doi: 10.1002/dta.369. Epub 2011 Oct 19.

DOI:10.1002/dta.369
PMID:22012825
Abstract

Since the expiration of patent protection, a number of new recombinant erythropoietin (rEPO) biosimilars have appeared on the worldwide market. In 2010, epoetin kappa, which is biosimilar to epoetin alfa, was clinically approved in Japan. Currently, both isoelectric focusing polyacrylamide gel electrophoresis (IEF-PAGE) and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) are approved by the World Anti-Doping Agency (WADA) for detection of rEPO doping. Because it was unclear whether epoetin kappa could be detected by WADA-accredited detection methods, intravenous administration studies of epoetin kappa, epoetin alfa, and epoetin beta were performed to test the applicability of these methods. The isoform bands of epoetin kappa expanded more widely towards the basic area and the profile appeared to be composed of at least eight bands, which were clearly different from those of other epoetins. The results showed that epoetin kappa also contains isoforms of higher molecular masses than those of originator epoetins on SDS-PAGE; the mass distribution was confirmed by electrospray ionization time-of-flight mass spectrometry. We clearly detected epoetin kappa after its administration up to 10 h by IEF-PAGE and 24 h by SDS-PAGE; the detection window of the SDS-PAGE is longer than that of the IEF-PAGE. SDS-PAGE compensates for the disadvantages of IEF-PAGE in detecting urinary epoetin kappa. We also concluded that athletes abusing rEPO might move to intravenous injections for shorter clearance times instead of subcutaneous injections. In conclusion, out-of-competition tests need to be applied more frequently to improve the effectiveness of the rEPO detection.

摘要

自专利保护期届满以来,许多新的重组促红细胞生成素(rEPO)生物类似物已在全球市场上出现。2010 年,与促红细胞生成素阿尔法具有生物相似性的促红素 kappa 在日本获得临床批准。目前,等电聚焦聚丙烯酰胺凝胶电泳(IEF-PAGE)和十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)均被世界反兴奋剂机构(WADA)批准用于检测 rEPO 兴奋剂。由于不清楚促红素 kappa 是否可以被 WADA 认可的检测方法检测到,因此进行了促红素 kappa、促红素阿尔法和促红素 beta 的静脉给药研究,以测试这些方法的适用性。促红素 kappa 的同工型条带向碱性区域更广泛地扩展,其形态似乎由至少 8 条带组成,这与其他促红素明显不同。结果表明,SDS-PAGE 上促红素 kappa 还含有比原研促红素更高分子量的同工型;通过电喷雾电离飞行时间质谱法证实了质量分布。我们通过 IEF-PAGE 清楚地检测到给药后 10 小时的促红素 kappa,通过 SDS-PAGE 检测到 24 小时的促红素 kappa;SDS-PAGE 的检测窗口比 IEF-PAGE 长。SDS-PAGE 弥补了 IEF-PAGE 检测尿液促红素 kappa 的缺点。我们还得出结论,滥用 rEPO 的运动员可能会转向静脉注射以缩短清除时间,而不是皮下注射。总之,需要更频繁地进行场外测试,以提高 rEPO 检测的有效性。

相似文献

1
Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application.静脉应用后生物类似依泊汀kappa 和其他重组促红细胞生成素的兴奋剂检测控制。
Drug Test Anal. 2011 Nov-Dec;3(11-12):798-805. doi: 10.1002/dta.369. Epub 2011 Oct 19.
2
Desialylation improves the detection of recombinant erythropoietins in urine samples analyzed by SDS-PAGE.唾液酸去除法提高 SDS-PAGE 分析尿液样本中重组红细胞生成素的检测。
Drug Test Anal. 2013 Nov-Dec;5(11-12):870-6. doi: 10.1002/dta.1494. Epub 2013 May 29.
3
SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control.重组和内源性促红细胞生成素的 SDS-PAGE:该方法在兴奋剂控制中的应用的优缺点。
Drug Test Anal. 2009 Jan;1(1):43-50. doi: 10.1002/dta.10.
4
Detection of recombinant erythropoietin biosimilar Jimaixin™ after administration in healthy subjects.在健康受试者中给药后重组促红素类似物济脉欣™的检测。
Drug Test Anal. 2022 Jan;14(1):72-79. doi: 10.1002/dta.3143. Epub 2021 Sep 2.
5
Practicing IEF-PAGE of EPO: the impact of detergents and sample application methods on analytical performance in doping control.IEF-PAGE 法检测 EPO 的实践:去污剂和样品加样方法对兴奋剂检测分析性能的影响。
Drug Test Anal. 2010 Nov-Dec;2(11-12):603-19. doi: 10.1002/dta.215.
6
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters.甲氧基聚乙二醇-红细胞生成素β(CERA,Mircera™)和红细胞生成素 δ(Dynepo™)单剂给药对等电点红细胞生成素谱和血液学参数的影响。
Drug Test Anal. 2011 May;3(5):291-9. doi: 10.1002/dta.270. Epub 2011 Mar 9.
7
Improved detection methods significantly increase the detection window for EPO microdoses.改进的检测方法显著增加了 EPO 微剂量的检测窗口期。
Drug Test Anal. 2021 Jan;13(1):101-112. doi: 10.1002/dta.2904. Epub 2020 Aug 9.
8
Defending Dynepo detection.捍卫达依泊汀检测。
Drug Test Anal. 2010 Nov-Dec;2(11-12):526-32. doi: 10.1002/dta.230. Epub 2010 Dec 1.
9
Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin.以重组促红细胞生成素为例的生物类似药分析的凝胶电泳方法
Bioanalysis. 2013 Mar;5(5):587-602. doi: 10.4155/bio.13.9.
10
Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.微剂量注射后,使用 EPO WGA MAIIA、IEF 和 SAR-PAGE 检测血液和尿液样本中的重组 EPO。
Drug Test Anal. 2013 Nov-Dec;5(11-12):861-9. doi: 10.1002/dta.1579.

引用本文的文献

1
Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.检测方法对自行车运动员促红细胞生成素(EPO)兴奋剂检测的灵敏度和特异性。
Drug Test Anal. 2019 Sep;11(9):1290-1301. doi: 10.1002/dta.2665. Epub 2019 Jul 17.
2
The Diversity of Biosimilar Design and Development: Implications for Policies and Stakeholders.生物类似药设计与开发的多样性:对政策和利益相关者的影响
BioDrugs. 2015 Dec;29(6):365-72. doi: 10.1007/s40259-015-0147-0.
3
Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study.
接受血液透析患者每周一次或两次给予促红细胞生成素κ的疗效:一项回顾性研究。
Exp Ther Med. 2014 Jan;7(1):27-30. doi: 10.3892/etm.2013.1384. Epub 2013 Nov 6.